Last updated: 5 March 2024 at 5:25pm EST

Geoffrey Craig Porges Net Worth




The estimated Net Worth of Geoffrey Craig Porges is at least $204 Tysiąc dollars as of 4 March 2024. Geoffrey Porges owns over 3,315 units of Schrodinger stock worth over $116,997 and over the last 2 years Geoffrey sold SDGR stock worth over $87,350.

Geoffrey Porges SDGR stock SEC Form 4 insiders trading

Geoffrey has made over 1 trades of the Schrodinger stock since 2024, according to the Form 4 filled with the SEC. Most recently Geoffrey sold 3,315 units of SDGR stock worth $87,350 on 4 March 2024.

The largest trade Geoffrey's ever made was selling 3,315 units of Schrodinger stock on 4 March 2024 worth over $87,350. On average, Geoffrey trades about 1,105 units every 0 days since 2022. As of 4 March 2024 Geoffrey still owns at least 5,685 units of Schrodinger stock.

You can see the complete history of Geoffrey Porges stock trades at the bottom of the page.



What's Geoffrey Porges's mailing address?

Geoffrey's mailing address filed with the SEC is 1540 BROADWAY, 24TH FLOOR, , NEW YORK, NY, 10036.

Insiders trading at Schrodinger

Over the last 5 years, insiders at Schrodinger have traded over $1,009,056,149 worth of Schrodinger stock and bought 838,235 units worth $14,249,995 . The most active insiders traders include & Melinda Gates Foundation ..., David E Schrodinger Equity ... oraz Michael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of $2,459,207. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth $24,191.



What does Schrodinger do?

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.



Complete history of Geoffrey Porges stock trades at Schrodinger

Osoba
Trans.
Transakcja
Łączna cena
Geoffrey Craig Porges
EVP i CFO
Sprzedaż $87,350
4 Mar 2024


Schrodinger executives and stock owners

Schrodinger executives and other stock owners filed with the SEC include: